Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neonatology

Confirming the Diagnosis

At a Glance

Congenital chylothorax is diagnosed by analyzing fluid drained from the newborn's chest for high triglycerides, lymphocytes, and chylomicrons. Doctors also use genetic testing to identify underlying lymphatic development issues, which helps guide the baby's treatment plan in the NICU.

Once your baby is born, the focus shifts from ultrasound images to direct testing of the fluid. This “postnatal” phase is critical for confirming the diagnosis and, more importantly, searching for the “why” behind the fluid buildup.

Analyzing the Pleural Fluid

To confirm a diagnosis of chylothorax, doctors must analyze the fluid drained from your baby’s chest (pleural fluid). This is usually done via a thoracocentesis (using a needle) or from a chest tube [1].

Doctors typically look for three key markers in the fluid:

  • Triglycerides: Chyle is very high in these fats. In older children and adults, a level over 110 mg/dL is diagnostic [1]. However, in newborns, there is no universally accepted “number,” and doctors must interpret this based on what the baby has eaten [2][3].
  • Lymphocytes: Chyle is rich in white blood cells called lymphocytes. A finding where more than 80% of the cells in the fluid are lymphocytes is a strong indicator of chylothorax [2].
  • Chylomicrons: These are tiny fat-transporting particles. Their presence in the fluid is considered the “gold standard” for diagnosis, as they are only found in chyle [4].

The “NPO” Challenge

If your baby is NPO (meaning “nothing by mouth”) or is only receiving IV fluids (Total Parenteral Nutrition), the fluid in their chest may not look like typical milky chyle [2].

Without fat from milk entering the digestive system, the triglyceride levels in the chest fluid can be falsely low [2]. In these cases, the medical team may need to re-test the fluid once the baby starts specialized feeding to get an accurate reading [2].

The Role of Genetic Testing

Because congenital chylothorax is often a symptom of a larger developmental issue in the lymphatic system, genetic testing is a standard part of the diagnostic journey [5][6]. Identifying a genetic cause can help the team predict the baby’s clinical course and choose the best treatments.

Common genetic associations include:

  • RASopathies: This is a group of syndromes, including Noonan Syndrome, which are frequently linked to lymphatic overgrowth or “leaky” vessels [5][7].
  • Trisomy 21 (Down Syndrome): This is one of the more common chromosomal associations with ductal chylothorax [8].
  • Generalized Lymphatic Dysplasia (GLD): Specific gene mutations can cause the entire lymphatic system to form incorrectly. Key genes often tested include:
    • RASA1: Linked to malformed lymphatic vessels [9][10].
    • PIEZO1: Associated with a specific form of GLD that causes severe fluid buildup (hydrops) [11][12].
    • CCBE1: Mutations here can cause Hennekam Syndrome, which involves lymphatic malformations and protein loss [13][14].

What to Ask For

As you navigate daily rounds in the NICU, you can ask for specific reports to help you stay informed:

  1. Pleural Fluid Analysis: Look for the triglyceride count and the percentage of lymphocytes [1].
  2. Lipoprotein Electrophoresis: This is the technical name for the test that looks for chylomicrons [4].
  3. Genetic Panel Results: Ask which specific genes were tested.

It is important to know that results for broad tests like “Whole Exome Sequencing” can take several weeks to return [6]. While waiting can be agonizing, your medical team will not wait to act. They will continue aggressively treating the fluid and supporting your baby’s breathing while these genetic puzzle pieces are being gathered.

Common questions in this guide

How is congenital chylothorax diagnosed after birth?
Doctors confirm congenital chylothorax by draining fluid from the baby's chest and analyzing it in a lab. They specifically look for a high percentage of white blood cells called lymphocytes, elevated triglyceride fats, and fat-transporting particles known as chylomicrons.
Why might my baby's chest fluid test be inaccurate if they are not eating?
If your baby is fasting or only receiving IV fluids, they are not digesting the fats that typically make up chyle. This lack of dietary fat can cause the triglyceride levels in the chest fluid to be falsely low, meaning doctors may need to re-test the fluid after the baby starts specialized feeding.
Why is genetic testing necessary for a chylothorax diagnosis?
Because congenital chylothorax is frequently caused by broader developmental issues in the lymphatic system, genetic testing is standard practice. Identifying specific genetic conditions, like Noonan Syndrome or Generalized Lymphatic Dysplasia, helps the medical team anticipate the baby's needs and tailor their treatment plan.
What does a pleural fluid analysis test for?
A pleural fluid analysis examines the liquid drained from the space around the lungs. For suspected chylothorax, the lab measures triglyceride levels, counts the lymphocytes, and checks for chylomicrons to verify that the fluid is indeed chyle.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were the specific triglyceride and lymphocyte levels in our baby's pleural fluid?
  2. 2.Was the fluid tested for the presence of chylomicrons, especially if our baby was fasting (NPO) at the time?
  3. 3.Given that our baby hasn't had much fat intake yet, do we need to re-test the fluid after starting specialized milk to confirm the diagnosis?
  4. 4.Which genetic panel did you order? Does it include testing for RASopathies (like Noonan syndrome) and Generalized Lymphatic Dysplasia (like RASA1 or PIEZO1)?
  5. 5.Can we have a copy of the 'Pleural Fluid Analysis' and any genetic reports for our records?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Recurrent non-traumatic idiopathic chylothorax: a diagnostic dilemma with therapeutic challenge.

    Vadala R, Talwar D, Talwar D

    Respirology case reports 2020; (8(7)):e00637 doi:10.1002/rcr2.637.

    PMID: 32884811
  2. 2

    Milky pleural effusion in a neonate and approach to investigating chylothorax.

    Senarathne UD, Rodrigo R, Dayanath BKTP

    BMJ case reports 2021; (14(9)) doi:10.1136/bcr-2021-245576.

    PMID: 34588205
  3. 3

    Management and outcomes of congenital chylothorax in the neonatal intensive care unit: A case series.

    Healy H, Gipson K, Hay S, et al.

    Pediatric investigation 2017; (1(1)):21-25 doi:10.1002/ped4.12007.

    PMID: 32851213
  4. 4

    Changing pleural fluid triglyceride levels in cirrhotic chylothorax.

    Chan KP, Yip WH, Chan TYC, Law CY

    Respirology case reports 2022; (10(3)):e0907 doi:10.1002/rcr2.907.

    PMID: 35169482
  5. 5

    Lymphangiography as a Treatment for Refractory Congenital Chylothorax Due to RASopathies: A Report of Two Cases.

    Kinota N, Kodama H, Moriyama T, et al.

    Interventional radiology (Higashimatsuyama-shi (Japan) 2022; (7(1)):17-20 doi:10.22575/interventionalradiology.2021-0014.

    PMID: 35911871
  6. 6

    Case report of generalized lymphatic dysplasia with PIEZO1 mutation and review of the literature.

    Alhazmi W, Qurban A, Alrashidi E

    Respiratory medicine case reports 2023; (44()):101872 doi:10.1016/j.rmcr.2023.101872.

    PMID: 37274623
  7. 7

    Thoracic Empyema Secondary to Congenital Chylothorax in a 14-Month-Old Boy with Noonan Syndrome.

    Oikawa T, Ota C, Iwasawa S, et al.

    Case reports in pediatrics 2021; (2021()):6620353 doi:10.1155/2021/6620353.

    PMID: 34012687
  8. 8

    Fetal Aneuploidy: A Comparison of Dichorionic Twins and Monochorionic Twins.

    Shi X, Li L, Huang X, et al.

    Fetal diagnosis and therapy 2018; (44(2)):124-128 doi:10.1159/000479685.

    PMID: 28869935
  9. 9

    Congenital Chylothorax and Hydrops Fetalis: A Novel Neonatal Presentation of RASA1 Mutation.

    Gallipoli A, MacLean G, Walia JS, Sehgal A

    Pediatrics 2021; (147(3)) doi:10.1542/peds.2020-011601.

    PMID: 33608416
  10. 10

    A case report of RASA1-associated inherited lymphoedema with recurrent life-threatening lymphangitis.

    Westphal DS, Bergmann K, Martens E, Ibrahim T

    European heart journal. Case reports 2021; (5(11)):ytab451 doi:10.1093/ehjcr/ytab451.

    PMID: 34859188
  11. 11

    PIEZO1 variant implications for biological understanding and human health.

    Cheng CW, Earle SL, Povstyan OV, et al.

    Open biology 2025; (15(7)):240345 doi:10.1098/rsob.240345.

    PMID: 40628291
  12. 12

    Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis.

    Fotiou E, Martin-Almedina S, Simpson MA, et al.

    Nature communications 2015; (6()):8085 doi:10.1038/ncomms9085.

    PMID: 26333996
  13. 13

    Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow.

    Betterman KL, Sutton DL, Secker GA, et al.

    The Journal of clinical investigation 2020; (130(6)):3315-3328.

    PMID: 32182215
  14. 14

    A Multiplex Kindred with Hennekam Syndrome due to Homozygosity for a CCBE1 Mutation that does not Prevent Protein Expression.

    Jackson CC, Best L, Lorenzo L, et al.

    Journal of clinical immunology 2016; (36(1)):19-27 doi:10.1007/s10875-015-0225-6.

    PMID: 26686525

This page explains diagnostic and genetic testing for congenital chylothorax for educational purposes. Always consult your neonatologist or pediatric geneticist to interpret your baby's specific lab and genetic results.

Get notified when new evidence is published on Congenital chylothorax.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.